Financials

News Discussions Technicals Seasonals

HBPCF fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Helix Biopharma Corp.

Total assets of HBPCF for Q3 24 is 831.06 k USD, 224.76% more than the previous Q2 24. And total liabilities increased by 143.52% in Q3 24 to 1.09 M USD.

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—